09:23 AM EST - Avalon GloboCare Corp. : Announced that Laboratory Services MSO, LLC is now offering an in-house laboratory developed test to detect Tuberculosis using a patient’s sputum sample. Avalon owns a 40% interest in LSM. LSM’s new polymerase chain reaction test allows for accurate and rapid identification of Mycobacterium tuberculosis from samples. The use of sputum samples to detect Mtb provides easier collection and transport than blood samples, which are used in protein-based chemiluminescent immuno-assays. Avalon GloboCare Corp.
shares N.ALBT are trading unchanged at $0.94.
Full Press Release: https://www.baystreet.ca/quotedata/quote.aspx?ticker=ALBT&qmodStoryID=8121623634417708
